Close
Found 0 results for your search. Showing 0 to 0.
No results could be found for your search.
x Close Search
Close

Publications

Broadening the age restriction for initiating rotavirus vaccination in regions with high rotavirus mortality: benefits of mortality reduction versus risk of fatal intussusception.
Patel, MM; CLARK, AD; Glass, RI; Greenberg, H; Tate, J; Santosham, M; SANDERSON, CF B; Steele, D; Cortese, M; Parashar, UD;
2009
Vaccine, (2009).27 22 10.1016/j.vaccine.2009.03.016.
Cost of treatment and QALYs lost due to genital warts: data for the economic evaluation of HPV vaccines in the United Kingdom.
Woodhall, SC; JIT, M; Cai, C; Ramsey, T; Zia, S; Crouch, S; Birks, Y; NEWTON, R; EDMUNDS, WJ; Lacey, CJ N;
2009
Sexually transmitted diseases, (2009).36 8 10.1097/OLQ.0b013e3181a74c2c.
Timing of children's vaccinations in 45 low-income and middle-income countries: an analysis of survey data.
CLARK, A; SANDERSON, C;
2009
Lancet, (2009).373 9674 10.1016/S0140-6736(09)60317-2.
Surface antigens of Plasmodium falciparum gametocytes--a new class of transmission-blocking vaccine targets?.
SUTHERLAND, CJ;
2009
Molecular and biochemical parasitology, (2009).166 2 10.1016/j.molbiopara.2009.03.007.
Japanese encephalitis: defining risk incidence for travelers to endemic countries and vaccine prescribing from the UK and Switzerland.
Hatz, C; Werlein, J; Mutsch, M; Hufnagel, M; BEHRENS, RH;
2009
Journal of travel medicine, (2009).16 3 10.1111/j.1708-8305.2009.00334.x.
Efficacy of killed whole-parasite vaccines in the prevention of leishmaniasis: a meta-analysis.
Noazin, S; Khamesipour, A; Moulton, LH; Tanner, M; Nasseri, K; Modabber, F; Sharifi, I; Khalil, EA G; Bernal, ID V; Antunes, CM F; SMITH, PG;
2009
Vaccine, (2009).27 35 10.1016/j.vaccine.2009.05.084.
Haemophilus influenzae type b disease in HIV-infected children: a review of the disease epidemiology and effectiveness of Hib conjugate vaccines.
MANGTANI, P; MULHOLLAND, K; Madhi, SA; EDMOND, K; O'Loughlin, R; Hajjeh, R;
2009
Vaccine, (2009).28 7 10.1016/j.vaccine.2009.12.011.
Pandemic influenza preparedness in Latin America: analysis of national strategic plans.
Mensua, A; MOUNIER-JACK, S; COKER, R;
2009
Health policy and planning, (2009).24 4 10.1093/heapol/czp019.
A chlamydial type III-secreted effector protein (Tarp) is predominantly recognized by antibodies from humans infected with Chlamydia trachomatis and induces protective immunity against upper genital tract pathologies in mice.
Wang, J; Chen, L; Chen, F; Zhang, X; Zhang, Y; Baseman, J; Perdue, S; Yeh, I-T; Shain, R; HOLLAND, M; BAILEY, R; MABEY, D; Yu, P; Zhong, G;
2009
Vaccine, (2009).27 22 10.1016/j.vaccine.2009.02.095.
Immunogenicity and Tolerability in Infants of a New Zealand Epidemic Strain Meningococcal B Outer Membrane Vesicle Vaccine.
Wong, SH; Lennon, DR; JACKSON, CM; Stewart, JM; Reid, S; Ypma, E; O'Hallahan, JM; Oster, P; MULHOLLAND, K; Martin, DR;
2009
The Pediatric infectious disease journal, (2009).28 5 10.1097/INF.0b013e318195205e.